Preclinical Publications

Comparison of Cisplatin with Lipoplatin in Terms of Ototoxicity2018
Lipoplatin CHUV Ris Hans-Beat manipulation of tumor blood vessels2018
Safety and efficacy of quadrapeutics versus chemoradiation in head and neck carcinoma xenograft model2015
Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer2013
Optimization of the route of platinum drugs administration to optimize the concomitant treatment with radiotherapy for glioblastoma implanted in the Fischer rat brain2013
Preparation, Biodistribution and Neurotoxicity of Liposomal Cisplatin following Convection Enhanced Delivery in Normal and F98 Glioma Bearing Rats2012
Glioblastoma Treatment: Bypassing the Toxicity of Platinum Compounds by Using Liposomal Formulation and Increasing Treatment Efficiency With Concomitant Radiotherapy2012
Cellular uptake and cytoplasm / DNA distribution of cisplatin and oxaliplatin and their liposomal formulation in human colorectal cancer cell HCT1162011
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatinTM)2011
Intrapleural administration of lipoplatin in an animal model2010
Concomitant treatment of F98 glioma cells with new liposomal platinum compounds and ionizing radiation2010
Distribution of Free and Liposomal Doxorubicin After Isolated Lung Perfusion in a Sarcoma Model2008
Activity of lipoplatin in tumor and in normal cells in vitro2008
Potential of the Akt inhibitor LY294005 to antagonize the efficacy of Cisplatin against HCT116 tumor cells in a DNA mismatch repair-dependent manner2006
MLH1-deficient tumor cells are resistant to lipoplatin, but retain sensitivity to lipoxal2005
Preclinical evaluation of a liposome-encapsulated formulation of cisplatin in clinically normal dogs2004
Low Renal Toxicity of Lipoplatin Compared to Cisplatin in Animals2004
Low toxicity and anticancer activity of a novel liposomal cisplatin (Lipoplatin) in mouse xenografts2004